IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances(VITA): A Phase 1 Study to Assess the Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects and Calf Vein DVT

University Of Michigan At Ann Arbor, Ann Arbor MI

Investigators

Abstract

The Vascular Interventions/Innovations and Therapeutic Advances (VITA) Program is a new translational initiative of the National Heart, Lung, and Blood Institute (NHLBI) that enables and accelerates the development of promising diagnostic and therapeutic modalities for unmet and underserved medical needs. The VITA Program provides contract support for early-stage translational development of product candidates in the fields of vascular disorders, thrombotic diseases, and pulmonary hypertension.